RTW Investments

General contacts

Investor type

PE / VC

Founded

2010

AUM

$8 800 M

Location

New York, New York, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Pre-seed Series B Late Stage (Series C+)

Region of investment

Europe North America Asia

Investor profile last updated: 16 August, 2026

Profile

RTW Investments is a life science investment and innovation firm based in New York City. Founded by a team of doctors, academics, venture capitalists, and drug developers, RTW focuses on advancing biotech and medtech innovations. The firm is distinguished by its integration of scientific expertise with investment acumen, assembled from seasoned investment bankers, experienced lawyers, and data scientists, to build successful life sciences companies around transformative ideas.

The firm invests across the full lifecycle of companies, from early-stage angel investments to public, multi-product companies. RTW specializes in the life sciences sector, with sub-sectors including biotechnology, medtech, and health tech. Their portfolio spans molecules managed by their own scientists to companies close to IPO. RTW emphasizes long-term relationships with its partner companies, going beyond financial support to offer scientific and management expertise.

Notable investments by RTW include Artiva - an immunotherapy developer, C4 - protein degradation technology, Dermtech - skin cancer diagnostics, Encoded Therapeutics - genetic medicines, Jixing - biopharmaceuticals, Stoke Therapeutics - RNA-targeted medicines, Tarsus - eye-disease treatments, and Ventyx Biosciences - inflammatory disease therapeutics.

Industry

MedTech HealthTech Biotechnology Healthcare Services Pharmaceuticals Life Sciences

RTW Investments Funds

Name	Type	Industry	Stage	Region	Size	AUM	Launch date
RTW Innovation Master Fund Ltd	Fund of funds	Biotechnology MedTech	Pre-seed Seed Series A Series B	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$3200 M	March 2016
RTW Biotech Opportunities Ltd	Venture Capital (VC)	Biotechnology Life Sciences	Seed Series A Series B Late Stage (Series C+)	North America South America Europe Middle East Africa Asia Australia and others	$5-10 m	$607 M	October 2019

Contacts

Name

Title

Social Networks

Brad Sitko Managing Director, Strategic Finance

Managing Director, Strategic Finance

b•••@•••

Lauren Cujé Venture Analyst

Venture Analyst

c•••@•••

Upgrade to see contacts

0GKbLSTRjkVgNE8B 0GKbLSTRjkVgNE8B

0GKbLSTRjkVgNE8B

[email protected]

0GKbLSTRjkVgNE8B 0GKbLSTRjkVgNE8B

0GKbLSTRjkVgNE8B

[email protected]

0GKbLSTRjkVgNE8B 0GKbLSTRjkVgNE8B

0GKbLSTRjkVgNE8B

[email protected]

Investment-team contacts for RTW Investments — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.

Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about RTW Investments

Is RTW Investments a venture capital or private equity firm?

RTW Investments is a venture capital and private equity firm. It backs companies at Series A, Seed, Pre-seed, Series B and Late Stage (Series C+), writing tickets of $10-50 m.

Where is RTW Investments located?

RTW Investments is located in New York, New York, United States.

When was RTW Investments founded?

RTW Investments was founded in 2010.

What sectors and industries does RTW Investments invest in?

RTW Investments invests in companies and startups in MedTech, HealthTech, Biotechnology, Healthcare Services, Pharmaceuticals, Life Sciences.

What is RTW Investments geographical focus of investments?

RTW Investments invests in companies and startups in Europe, North America, Asia.

At what stages of companies and startups does RTW Investments typically invest in?

RTW Investments invests in companies and startups at Series A, Seed, Pre-seed, Series B, Late Stage (Series C+).

What is the usual amount of RTW Investments investment?

RTW Investments usually invests $10-50 m on average.

What is the amount of assets of under management (AUM) for RTW Investments?

RTW Investments has around $8 800m assets under management.

When was RTW Investments last fund created?

RTW Investments last fund was created/launched in 2019-10-30

What are the contacts of RTW Investments?

RTW Investments can be reached through its website rtwfunds.com, its LinkedIn page and its X account. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for RTW Investments — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

Can I access RTW Investments data via API or MCP?

Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query RTW Investments directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.

When was the RTW Investments profile last updated?

Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.